SPOTLIGHT -
Mike Hollan is an assistant managing editor for Pharmaceutical Executive and Medical Device and Technology and can be reached at mhollan@mjhlifesciences.com.
Research Lab Unveils Tool to Improve Clinical Trial Participation
Cold Spring Harbor Laboratory details how the new tool will help reduce common barriers to trial participation.
Breaking Down the Inflation Reduction Act: Q&A with Alice Valder Curran, Partner at Hogan Lovells
Valder Curran discusses recent developments with the IRA.
OncoHost Wins AI Excellence Award
The technology platform won the award for its work using AI to improve precision medicine.
Cambrex Plans to Complete $100 Million Investment Strategy Earlier Then Planned
The company will see the completion of its projects about a year earlier than expected.
AstraZeneca Announces Plans to Acquire Fusion
The acquisition will bolster AstraZeneca’s ability to develop radioconjugates for cancer treatments.
Lunit Expands AI Cancer Screening to France and Portugal
The company’s software will be used to help with chest and breast cancer screenings.
New Report Shows AI Improved Treatments for Biofilm Infections
The technology was used to develop new peptides.
Deadly Brain Tumors May Be Treatable with New CAR-T Therapy, Study Suggests
The therapies are still in the early stages of development, but researchers are optimistic about the results.
BeiGene and Leukemia & Lymphoma Society Sign Three Year Agreement
As part of the partnership, BeiGene will serve as a sponsor at LLS events.
Eli Lilly Partners with Amazon Pharmacy
The online retailer will be able to provide customers with a selection of migraine, obesity, and diabetes medications.
ADHD Medication May Reduce Mortality Among Patients, New Study Suggests
The study, out of Sweden, researched the impact of the use of medication and mortality rates for patients with ADHD.
AION Labs Launches New Platform to Reduce Time and Cost of Antibody Development
The platform will allow for a more direct method of antibody optimization.
Bringing Real World Data to Clinical Studies: Q&A With Dr. David Cosgrove of Compass Oncology
Cosgrove discusses how a recent study utilized a high-tech data platform to bring a new perspective on data to the researchers.
Par Pharmaceutical Issues Recall of Single Lot of Treprostinil
The voluntary recall was ordered due to potential silicon particulate exposure.
Investing in Stability: Q&A With James Sapirstein, CEO of First Wave BioPharma
Sapirstein discusses the current conditions that are impacting investors’ view of the life sciences industry.
Straight and Simple Advice Lives On in the Pharma Industry
Classic views on leadership are sometimes still the most effective.
Finding the Right Patients: Q&A With Lisa Ricciardi, CEO of Cognition Therapies, Inc.
Ricciardi discusses how new treatments require much more specific patient groups in studies.
The Growing Non-Hallucinogenic Psychedelic Pipeline: Q&A with Joe Tucker, CEO of Enveric Biosciences
Tucker discusses the possibilities that non-hallucinogenic psychedelics bring to the sector.
Weight Loss Industry Market Hit New High in 2023 Due to Weight Loss Drugs and Other Medical Interventions
The medical side of the market is growing while the commercial side seems to be struggling.
Normalizing Data with AI: Q&A with Andrew Anderson, VP of Innovation and Informatics Strategy at ACD/Labs
Anderson discusses how AI can be used to take data collected by different processes and bring it into a usable format.
Standard Industries Announces Challenge to Bring AI Into Molecular Synthesis
The winner will receive $1 million and the chance to partner with a major industry leader.
An Entire Flu Strain Was Seemingly Wiped Out During COVID-19 Pandemic
Researchers are debating whether to still include protection for this strain in vaccines.
Branding in the Digital Age: Q&A with Justin Chase, Executive Vice President of EVERSANA INTOUCH
Chases discusses how traditional media platforms still coexist with digital platforms and how this impacts promotion.
Bayer Won’t Be Splitting Up
The company plans to spend the coming years strengthening its market position and pipeline while also clearing its issues with litigation and debt.
Digital Tools and Rising Biopharma Manufacturing Costs: Q&A with Barry Heavey, Supply Chain Lead at Accenture
Heavey discusses how the industry can avoid having efforts to accelerate discovery and development be hampered by manufacturing concerns.
Bringing Neuroplastogens to the Window: Q&A With Delix CEO Mark Rus
Rus discusses his company’s work with neuroplastogens and how they differ from similar, psychedelic treatments.
WebMD Ignite Announces Collaboration with FDB
The partnership has the goal of improving patient education and treatment directions.
Neuropathy Action Foundation Releases White Paper On Adjusting Policies for Gene Therapies
The paper discusses multiple steps the industry can take to ensure that patients have access to these treatments.
Redefining Commercial with Modern Data for Today’s Complex Therapies: Q&A with Peter Stark, Executive VP and General Manager of Veeva Compass
Stark discusses how the ways that data is reshaping commercial strategies.
The State of Obesity-Related Clinical Research: Q&A with Simon Bruce, Vice President, Internal Medicine, Drug Development Solutions, ICON
Simon discusses a recent survey ICON conducted with professionals in obesity-related clinical research.